Skip to main
AVNT

Avient Corp (AVNT) Stock Forecast & Price Target

Avient Corp (AVNT) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Avient Corp has demonstrated robust performance, with organic sales increasing by 5%, indicative of strong demand dynamics across its key segments. The healthcare sector is particularly noteworthy, achieving double-digit growth for six consecutive quarters and a year-over-year increase of 14% in the first half of 2025. Additionally, four out of nine end markets that constitute 40% of Avient's sales are experiencing growth, suggesting a diversified portfolio that is resilient amid challenges in certain markets, positioning the company favorably for future financial performance.

Bears say

Avient Corp is experiencing a decline in organic sales, with a notable drop of approximately 2% in the first quarter of 2024, suggesting potential instability in revenue generation. The weakening demand for chemicals, anticipated to further affect sales volumes in the second half of 2025, raises concerns regarding the company's future performance. Additionally, despite a slight depreciation of the dollar providing some potential tailwinds, the overall market challenges could overshadow this benefit and impact Avient's profitability negatively.

Avient Corp (AVNT) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Avient Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Avient Corp (AVNT) Forecast

Analysts have given Avient Corp (AVNT) a Buy based on their latest research and market trends.

According to 6 analysts, Avient Corp (AVNT) has a Buy consensus rating as of Jan 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $46, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $46, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Avient Corp (AVNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.